Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia

Biological Psychiatry

Volumn 54, Issue 11, 2003, Pages 1222-1233

  Martin Ruiz, Carmen M ^a   Haroutunian, Vahram H ^b   Long, Philip ^a   Young, Allan H ^c   Davis, Kenneth L ^b   Perry, Elaine K ^a   Court, Jennifer A ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Dorsolateral prefrontal cortex; Epibatidine binding; Nicotinic acetylcholine receptors; Schizophrenia; Subunit expression; 7

Indexed keywords

COTININE; EPIBATIDINE; NICOTINE; NICOTINIC RECEPTOR; RECEPTOR SUBUNIT; TRITIUM;

ADULT; AGED; ARTICLE; AUTOPSY; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; NUCLEOTIDE SEQUENCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; SCHIZOPHRENIA;

EID: 0344861848     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(03)00348-2     Document Type: Article

References (92)

1. Adler L.E., Hoffer L.J., Griffith J., Waldo M.C., Freedman R. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol Psychiatry. 32:1992;607-616.
2. Adler L.E., Hoffer L.D., Wiser A., Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry. 150:1993;1856-1861.
3. Alkondon M., Pereira E.F., Eisenberg H.M., Albuquerque E.X. Nicotinic receptor activation in human cerebral cortical interneurons A mechanism for inhibition and disinhibition of neuronal networks . J Neurosci. 20:2000;66-75.
4. Arnold S.E., Franz B.R., Trojanowski J.Q., Moberg P.J., Gur R.E. Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia. Acta Neuropathol (Berl). 91:1996;269-277.
5. Benowitz N.L., Porchet H., Jacob P.R. Pharmacokinetics, metabolism, and pharmacodynamics of nicotine. Wonnacott S., Russell M.A.H., Stolerman I.P. Nicotine Psychopharmacology. 1990;112-157 Oxford University Press, New York.
6. Bertolino A., Callicott J.H., Elman I., Mattay V.S., Tedeschi G., Frank J.A., et al. Regionally specific neuronal pathology in untreated patients with schizophrenia A proton magnetic resonance spectroscopic imaging study . Biol Psychiatry. 43:1998;641-648.
7. Breese C.R., Freedman R., Leonard S.S. Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers. Brain Res. 674:1995;82-90.
8. Breese C.R., Lee M.J., Adams C.E., Sullivan B., Logel J., Gillen K.M., et al. Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology. 23:2000;351-364.
9. Breese C.R., Marks M.J., Logel J., Adams C.E., Sullivan B., Colins A.C., et al. Effect of smoking history on [3H] nicotine binding in human postmortem brain. J Pharmacol Exp Ther. 282:1997;7-13.
10. Bunney W.E., Bunney B.G. Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia. Brain Res Brain Res Rev. 31:2000;138-146.
11. Cabeza R., Dolcos F., Graham R., Nyberg L. Similarities and differences in the neural correlates of episodic memory retrieval and working memory. Neuroimage. 16:2002;317-330.
12. Collins A.C., Marks M.J. Are nicotinic receptors activated or inhibited following chronic nicotine treatment? Drug Dev Res. 38:1996;231-242.
13. Collins A.C., Romm E., Wehner J.M. Dissociation of the apparent relationship between nicotine tolerance and up-regulation of nicotinic receptors. Brain Res Bull. 25:1990;373-379.
14. Cornette L., Dupont P., Orban G.A. The neural substrate of orientation short-term memory and resistance to distractor items. Eur J Neurosci. 15:2002;165-175.
15. Court J., Martin-Ruiz C., Piggott M., Spurden D., Griffiths M., Perry E. Nicotinic receptor abnormalities in Alzheimer's disease. Biol Psychiatry. 49:2001;175-184.
16. Court J., Spurden D., Lloyd S., McKeith I., Ballard C., Cairns N., et al. Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia Alpha-bungarotoxin and nicotine binding in the thalamus . J Neurochem. 73:1999;1590-1597.
17. Court J.A., Ballard C.G., Piggott M.A., Johnson M., O'Brien J.T., Holmes C., et al. Visual hallucinations are associated with lower alphabungarotoxin binding in dementia with Lewy bodies. Pharmacol Biochem Behav. 70:2001;571-579.
18. Court J.A., Lloyd S., Johnson M., Griffiths M., Birdsall N.J., Piggott M.A., et al. Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging. Brain Res Dev Brain Res. 101:1997;93-105.
19. Court J.A., Lloyd S., Thomas N., Piggott M.A., Marshall E.F., Morris C.M., et al. Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use. Neuroscience. 87:1998;63-78.
20. Court J.A., Perry E.K., Spurden D., Griffiths M., Kerwin J.M., Morris C.M., et al. The role of the cholinergic system in the development of the human cerebellum. Brain Res Dev Brain Res. 90:1995;159-167.
21. Court J.A., Piggott M.A., Lloyd S., Cookson N., Ballard C.G., McKeith I.G., et al. Nicotine binding in human striatum Elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication . Neuroscience. 98:2000;79-87.
22. Davidson M., Harvey P., Welsh K.A., Powchik P., Putnam K.M., Mohs R.C. Cognitive functioning in late-life schizophrenia A comparison of elderly schizophrenic patients and patients with Alzheimer's disease . Am J Psychiatry. 153:1996;1274-1279.
23. Davidson M., Harvey P.D., Powchik P., Parrella M., White L., Knobler H.Y., et al. Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. Am J Psychiatry. 152:1995;197-207.
24. Dean B., Crook J.M., Opeskin K., Hill C., Keks N., Copolov D.L. The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia. Mol Psychiatry. 1:1996;54-58.
25. de Leon J., Dadvand M., Canuso C., White A.O., Stanilla J.K., Simpson G.M. Schizophrenia and smoking An epidemiological survey in a state hospital . Am J Psychiatry. 152:1995;453-455.
26. Dracheva S., Marras S.A., Elhakem S.L., Kramer F.R., Davis K.L., Haroutunian V. N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Am J Psychiatry. 158:2001;1400-1410.
27. Durany N., Zochling R., Boissl K.W., Paulus W., Ransmayr G., Tatschner T., et al. Human post-mortem striatal α4β2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome. Neurosci Lett. 287:2000;109-112.
28. el-Mallakh R.S., Kirch D.G., Shelton R., Fan K.J., Pezeshkpour G., Kanhouwa S., et al. The nucleus basalis of Meynert, senile plaques, and intellectual impairment in schizophrenia. J Neuropsychiatry Clin Neurosci. 3:1991;383-386.
29. Ernst M., Bolla K., Mouratidis M., Contoreggi C., Matochik J.A., Kurian V., et al. Decision-making in a risk-taking task A PET study . Neuropsychopharmacology. 26:2002;682-691.
30. Falkai P., Honer W.G., David S., Bogerts B., Majtenyi C., Bayer T.A. No evidence for astrogliosis in brains of schizophrenic patients. A post-mortem study. Neuropathol Appl Neurobiol. 25:1999;48-53.
31. Feyerabend C., Russell M.A. A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids. J Pharm Pharmacol. 42:1990;450-452.
32. Flores C.M., Davila-Garcia M.I., Ulrich Y.M., Kellar K.J. Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration. J Neurochem. 69:1997;2216-2219.
33. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Oliney A., Davis A., et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci U S A. 94:1997;587-592.
34. Freedman R., Hall M., Adler L.E., Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry. 38:1995;22-33.
35. Freedman R., Leonard S., Gault J.M., Hopkins J., Cloninger C.R., Knufmann C.A., et al. Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7). Am J Med Genet. 105:2001;20-22.
36. Gault J., Robinson M., Berger R., Drebing C., Logel J., Hopkins J., et al. Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics. 52:1998;173-185.
37. Gluck M.R., Thomas R.G., Davis K.L., Haroutunian V. Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients. Am J Psychiatry. 159:2002;1165-1173.
38. Graham A.J., Martin-Ruiz C.M., Teaktong T., Ray M.A., Court J.A. Human brain nicotinic receptors, their distribution and participation in neuropsychiatric disorders. Curr Drug Targets CNS Neurol Disord. 1:2002;387-397.
39. Guan Z.Z., Zhang X., Blennow K., Nordberg A. Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain. Neuroreport. 10:1999;1779-1782.
40. Gur R.E., Cowell P., Turetsky B.I., Gallacher F., Cannon T., Bilker W., et al. A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry. 55:1998;145-152.
41. Haroutunian V., Davidson M., Kanof P.D., Perl D.P., Powchik P., Losoncay M., et al. Cortical cholinergic markers in schizophrenia. Schizophr Res. 12:1994;137-144.
42. Harvey P.D. Cognitive impairment in elderly patients with schizophrenia Age related changes . Int J Geriatr Psychiatry. 16:(suppl 1):2001;S78-S85.
43. Harvey P.D., Howanitz E., Parrella M., White L., Davidson M., Mohn R.C., et al. Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia A comparison across treatment sites . Am J Psychiatry. 155:1998;1080-1086.
44. Heckers S. Neuropathology of schizophrenia Cortex, thalamus, basal ganglia, and neurotransmitter-specific projection systems . Schizophr Bull. 23:1997;403-421.
45. Hellstrom-Lindahl E., Mousavi M., Zhang X., Ravid R., Nordberg A. Regional distribution of nicotinic receptor subunit mRNAs in human brain Comparison between Alzheimer and normal brain . Brain Res Mol Brain Res. 66:1999;94-103.
46. Ichinose H., Ohye T., Fujita K., Pantucek F., Lange K., Riederer P., et al. Quantification of mRNA of tyrosine hydroxylase and aromatic L-amino acid decarboxylase in the substantia nigra in Parkinson's disease and schizophrenia. J Neural Transm Park Dis Dement Sect. 8:1994;149-158.
47. Kapur S., Remington G. Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry. 153:1996;466-476.
48. Karson C.N., Casanova M.F., Kleinman J.E., Griffin W.S. Choline acetyltransferase in schizophrenia. Am J Psychiatry. 150:1993;454-459.
49. Kay S (1991): Positive and negative syndromes in schizophrenia: Assessment and research. Clinical and Experimental Psychiatry. New York, NY: Brunner/Mazel.
50. Kelley W.M., Miezin F.M., McDermott K.B., Buckner R.L., Raichle M.E., Cohen N.J., et al. Hemispheric specialization in human dorsal frontal cortex and medial temporal lobe for verbal and nonverbal memory encoding. Neuron. 20:1998;927-936.
51. Kornhuber J., Schultz A., Wiltfang J., Meineke I., Gleiter C.H., Zochling R., et al. Persistence of haloperidol in human brain tissue. Am J Psychiatry. 156:1999;885-890.
52. Krenz I., Kalkan D., Wevers A., de Vos R.A., Steur E.N., Lindstrom J., et al. Parvalbumin-containing interneurons of the human cerebral cortex express nicotinic acetylcholine receptor proteins. J Chem Neuroanat. 21:2001;239-246.
53. Kroger J.K., Sabb F.W., Fales C.L., Bookheimer S.Y., Cohen M.S., Holyoak K.J. Recruitment of anterior dorsolateral prefrontal cortex in human reasoning A parametric study of relational complexity . Cereb Cortex. 12:2002;477-485.
54. Lee P.N. Passive smoking and lung cancer association A result of bias? Hum Toxicol. 6:1987;517-524.
55. Liu C.M., Hwu H.G., Lin M.W., Ou-Yang W.C., Lee S.F., Fann C.S., et al. Suggestive evidence for linkage of schizophrenia to markers at chromosome 15q13-14 in Taiwanese families. Am J Med Genet. 105:2001;658-661.
56. Lohr J.B., Flynn K. Smoking and schizophrenia. Schizophr Res. 8:1992;93-102.
57. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein Measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
58. Lukas R., Ke L., Bencherif M., Eisenlour C. Regulation by nicotine of its own receptors. Drug Dev Res. 38:1996;136-148.
59. Manes F., Sahakian B., Clark L., Rogers R., Antoun N., Aitken M., et al. Decision-making processes following damage to the prefrontal cortex. Brain. 125:2002;624-639.
60. Marks M.J., Pauly J.R., Gross S.D., Deneris D.S., Hermans-Borgmeyor I., Heinemann S.F., et al. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci. 12:1992;2765-2784.
61. Martin-Ruiz C.M., Piggott M., Gotti C., Lindstrom J., Mendelow A.D., Siddique J.S., et al. Alpha and beta nicotinic acetylcholine receptors subunits and synaptophysin in putamen from Parkinson's disease. Neuropharmacology. 39:2000;2830-2839.
62. 3H]epibatidine. Brain Res. 801:1998;143-149.
63. Marutle A., Zhang X., Court J., Piggott M., Johnson M., Perry R., et al. Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia. J Chem Neuroanat. 22:2001;115-126.
64. Meador-Woodruff J.H., Davis K.L., Haroutunian V. Abnormal kainate receptor expression in prefrontal cortex in schizophrenia. Neuropsychopharmacology. 24:2001;545-552.
65. Mukherjee S., Mahadik S.P., Korenovsky A., Laer H., Schnur D.B., Reddy R. Serum antibodies to nicotinic acetylcholine receptors in schizophrenic patients. Schizophr Res. 12:1994;131-136.
66. Noga J.T., Hyde T.M., Herman M.M., Spurney C.F., Bigelow L.B., Weinberger D.R., et al. Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains. Synapse. 27:1997;168-176.
67. Pauly J.R., Marks M.J., Gross S.D., Collins A.C. An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment. J Pharmacol Exp Ther. 258:1991;1127-1136.
68. Perry E.K., Smith C.J., Court J.A., Perry R.H. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types. J Neural Transm Park Dis Dement Sect. 2:1990;149-158.
69. Picciotto M.R., Caldarone B.J., King S.L., Zachariou V. Nicotinic receptors in the brain. Links between molecular biology and behavior. Neuropsychopharmacology. 22:2000;451-465.
70. Prohovnik I., Dwork A.J., Kaufman M.A., Willson N. Alzheimer-type neuropathology in elderly schizophrenia patients. Schizophr Bull. 19:1993;805-816.
71. Purohit D.P., Perl D.P., Haroutunian V., Powchik P., Davidson M., Davis K.L. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia A postmortem neuropathologic study of 100 cases . Arch Gen Psychiatry. 55:1998;205-211.
72. Rajkowska G., Miguel-Hidalgo J., Makkos Z., Meltzer H., Overholser J., Stockmeier C. Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. Schizophr Res. 57:2002;127.
73. Rapoport J.L., Giedd J.N., Blumenthal J., Hamburger S., Jeffries N., Fernandez T., et al. Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study. Arch Gen Psychiatry. 56:1999;649-654.
74. Reid R.T., Sabbagh M.N., Corey-Bloom J., Tiraboschi P., Thal L.J. Nicotinic receptor losses in dementia with Lewy bodies Comparisons with Alzheimer's disease . Neurobiol Aging. 21:2000;741-746.
75. Rezvani A.H., Levin E.D. Cognitive effects of nicotine. Biol Psychiatry. 49:2001;258-267.
76. Riley B., Williamson M., Collier D., Wilkie H., Makoff A. A 3-Mb map of a large Segmental duplication overlapping the alpha7-nicotinic acetylcholine receptor gene (CHRNA7) at human 15q13-q14. Genomics. 79:2002;197-209.
77. Rugg M.D., Otten L.J., Henson R.N. The neural basis of episodic memory Evidence from functional neuroimaging . Philos Trans R Soc Lond B Biol Sci. 357:2002;1097-1110.
78. Rypma B., Berger J.S., D'Esposito M. The influence of working-memory demand and subject performance on prefrontal cortical activity. J Cogn Neurosci. 14:2002;721-731.
79. Sanderson E.M., Drasdo A.L., McCrea K., Wonnacott S. Upregulation of nicotinic receptors following continuous infusion of nicotine is brain-region-specific. Brain Res. 617:1993;349-352.
80. Sedvall G., Farde L. Chemical brain anatomy in schizophrenia. Lancet. 346:1995;743-749.
81. Sharma G., Vijayaraghavan S. Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores. Proc Natl Acad Sci U S A. 98:2001;4148-4153.
82. Shenton M.E., Dickey C.C., Frumin M., McCarley R.W. A review of MRI findings in schizophrenia. Schizophr Res. 49:2001;1-52.
83. Stassen H.H., Bridler R., Hagele S., Hergersberg M., Mehmann B., Schinzel A., et al. Schizophrenia and smoking Evidence for a common neurobiological basis? Am J Med Genet. 96:2000;173-177.
84. Tandon R., Greden J.F. Cholinergic hyperactivity and negative schizophrenic symptoms. A model of cholinergic/dopaminergic interactions in schizophrenia. Arch Gen Psychiatry. 46:1989;745-753.
85. Tiraboschi P., Hansen L.A., Alford M., Sabbagh M.N., Schoos B., Masliah E., et al. Cholinergic dysfunction in diseases with Lewy bodies. Neurology. 54:2000;407-411.
86. Tsuang D.W., Skol A.D., Faraone S.V., Bingham S., Young K.A., Prabhadesai S., et al. Examination of genetic linkage of chromosome 15 to schizophrenia in a large Veterans Affairs Cooperative Study sample. Am J Med Genet. 105:2001;662-668.
87. Utsugisawa K., Nagane Y., Tohgi H., Yoshimura M., Ohba H., Genda Y. Changes with aging and ischemia in nicotinic acetylcholine receptor subunit alpha7 mRNA expression in postmortem human frontal cortex and putamen. Neurosci Lett. 270:1999;145-148.
88. Wagner A.D., Poldrack R.A., Eldridge L.L., Desmond J.E., Glover G.H., Gabrieli J.D. Material-specific lateralization of prefrontal activation during episodic encoding and retrieval. Neuroreport. 9:1998;3711-3717.
89. Weickert C.S., Webster M.J., Hyde T.M., Herman M.M., Bachus S.E., Bali G., et al. Reduced GAP-43 mRNA in dorsolateral prefrontal cortex of patients with schizophrenia. Cereb Cortex. 11:2001;136-147.
90. Wevers A., Monteggia L., Nowacki S., Block W., Schutz U., Lindstrom J., et al. Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease Histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein . Eur J Neurosci. 11:1999;2551-2565.
91. Ziedonis D.M., Kosten T.R., Glazer W.M., Frances R.J. Nicotine dependence and schizophrenia. Hosp Community Psychiatry. 45:1994;204-206.
92. Zoli M., Lena C., Picciotto M.R., Changeux J.P. Identification of four classes of brain nicotinic receptors using beta2 mutant mice. J Neurosci. 18:1998;4461-4472.